SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?


To: mokelumne river who wrote (1219)5/28/2015 4:48:28 PM
From: mokelumne river  Read Replies (2) | Respond to of 2026
 
One major market of the approved countries to go, Italy. Arguably Italy should have been first with Bracco's subsidiary Therapex manufacturing the first batches of Vitaros. Oh well.

Pascoe did repeat that RayVa results would be in June as well as the Fis trial start. So we are on track.